Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study.

Ângela Cristine Bersch-Ferreira, Geni Rodrigues Sampaio, Marcella Omena Gehringer, Elizabeth Aparecida Ferraz da Silva Torres, Maria Beatriz Ross-Fernandes, Jacqueline Tereza da Silva, Camila Ragne Torreglosa, Cristiane Kovacs, Renata Alves, Carlos Daniel Magnoni, Bernardete Weber, Marcelo Macedo Rogero

Journal: Nutrition journal 2019;17(1):26

PMID: 29466985

Plain Language Summary

plain language summary logo

It is known that people with cardiovascular disease (CVD) have increased inflammation and raised levels of circulating inflammatory molecules. The presence of insulin resistance is thought to increase these levels, as are certain fatty acids coming from dietary fats. The aims of this cross-sectional study were to compare the levels of inflammatory biomarkers in patients with CVD with and without insulin resistance, and to evaluate the possible link between the blood levels of fatty acids and inflammatory biomarkers among these patients. The authors concluded that the CVD patients with insulin resistance had a higher concentration of some inflammatory molecules in the blood than those without insulin resistance. They also observed that saturated fatty acids were linked to higher levels of inflammatory molecules in the blood, while unsaturated fatty acids correlated with lower levels.

Abstract

BACKGROUND

Proinflammatory biomarkers levels are increased among patients with cardiovascular disease, and it is known that both the presence of insulin resistance and diet may influence those levels. However, these associations are not well studied among patients with established cardiovascular disease. Our objective is to compare inflammatory biomarker levels among cardiovascular disease secondary prevention patients with and without insulin resistance, and to evaluate if there is any association between plasma fatty acid levels and inflammatory biomarker levels among them.

METHODS

In this cross-sectional sub-study from the BALANCE Program Trial, we collected data from 359 patients with established cardiovascular disease. Plasma fatty acids and inflammatory biomarkers (interleukin (IL)-1β, IL-6, IL-8, IL-10, IL-12, high sensitive C-reactive protein (hs-CRP), adiponectin, and tumor necrosis factor (TNF)-alpha) were measured. Biomarkers and plasma fatty acid levels of subjects across insulin resistant and not insulin resistant groups were compared, and general linear models were used to examine the association between plasma fatty acids and inflammatory biomarkers.

RESULTS

Subjects with insulin resistance had a higher concentration of hs-CRP (p = 0.002) and IL-6 (p = 0.002) than subjects without insulin resistance. Among subjects without insulin resistance there was a positive association between stearic fatty acid and IL-6 (p = 0.032), and a negative association between alpha-linolenic fatty acid and pro-inflammatory biomarkers (p < 0.05). Among those with insulin resistance there was a positive association between monounsaturated fatty acids and arachidonic fatty acid and adiponectin (p < 0.05), and a negative association between monounsaturated and polyunsaturated fatty acids and pro-inflammatory biomarkers (p < 0.05), as well as a negative association between polyunsaturated fatty acids and adiponectin (p < 0.05). Our study has not found any association between hs-CRP and plasma fatty acids.

CONCLUSIONS

Subjects in secondary prevention for cardiovascular disease with insulin resistance have a higher concentration of hs-CRP and IL-6 than individuals without insulin resistance, and these inflammatory biomarkers are positively associated with saturated fatty acids and negatively associated with unsaturated fatty acids.

Address: Research Institute, Hospital do Coração (IP-HCor), São Paulo, SP, Brazil.; Department of Nutrition, School of Public Health, University of São Paulo, São Paulo, Brazil.; Department of Nutrition, School of Public Health, University of São Paulo, São Paulo, Brazil.; Research Institute, Hospital do Coração (IP-HCor), São Paulo, SP, Brazil.; Department of Clinical Nutrition at Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.; Department of Nutrition, School of Public Health, University of São Paulo, São Paulo, Brazil.; Department of Clinical Nutrition at Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.; Department of Nutrition, School of Public Health, University of São Paulo, São Paulo, Brazil. [email protected].; University of São Paulo (USP), Av Dr Arnaldo, 715, São Paulo, SP, 01246-904, Brazil. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.